









Markets
/
Stocks
/
nasdaq-rvp
/

Retractable Technologies Inc

RVP

0.857USD

+0.016+1.88%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

25.65MMarket Cap

LossP/E TTM



Retractable Technologies Inc

0.857

+0.016+1.88%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Retractable Technologies Inc

Currency: USD Updated: 2025-11-05

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Retractable Technologies Inc's Score

Industry at a Glance

Industry Ranking

150 / 210

Overall Ranking

407 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Retractable Technologies Inc Highlights

StrengthsRisks

Retractable Technologies, Inc. is engaged in manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

Growing

The company is in a growing phase, with the latest annual income totaling USD 33.05M.

Fairly Valued

The company’s latest PE is -2.86, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 2.10M shares, decreasing 31.18% quarter-over-quarter.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.17.

Financial Health

Currency: USD Updated: 2025-11-05

The company's current financial score is 6.62, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 10.45M, representing a year-over-year increase of 73.25%, while its net profit experienced a year-over-year increase of 98.98%.

Score

Industry at a Glance

Previous score

6.62

Change



Financials

4.75

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

5.63

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.63

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.11

Key Metrics

Free cash flow

No Data

Retractable Technologies Inc's Company Valuation

Currency: USD Updated: 2025-11-05

The company’s current valuation score is 7.47, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -2.86, which is -581.92% below the recent high of 13.78 and -1256.08% above the recent low of -38.78.

Score

Industry at a Glance

Previous score

7.47

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 150/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-05

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.74.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-05

The company’s current price momentum score is 6.56, which is lower than the Healthcare Equipment & Supplies industry's average of 6.82. Sideways: Currently, the stock price is trading between the resistance level at 1.06 and the support level at 0.74, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.51

Change

0.05

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.034

Neutral

RSI(14)

43.958

Neutral

STOCH(KDJ)(9,3,3)

12.917

Oversold

ATR(14)

0.086

Low Volatility

CCI(14)

-97.183

Neutral

Williams %R

90.191

Oversold

TRIX(12,20)

0.016

Sell

StochRSI(14)

51.621

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

0.865

Sell

MA10

0.896

Sell

MA20

0.937

Sell

MA50

0.874

Sell

MA100

0.795

Buy

MA200

0.767

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-05

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Shaw (Thomas J)

16.18M

+0.21%

Larios Michele Mitchell

861.00K

The Vanguard Group, Inc.

Star Investors

673.81K

-2.28%

Renaissance Technologies LLC

Star Investors

348.41K

-3.12%

BlackRock Institutional Trust Company, N.A.

245.16K

-9.72%

Bridgeway Capital Management, LLC

155.63K

Geode Capital Management, L.L.C.

128.11K

-0.11%

Laterza (Marco)

85.00K

Bigby (Walter O Jr)

80.00K

Axiom Asset Management

73.03K

-28.07%

Risk Assessment

Currency: USD Updated: 2025-11-05

The company’s current risk assessment score is 3.65, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.14. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.